Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer.

Andrea Sartore-BianchiEmanuele ValtortaAlessio AmatuSilvio VeroneseCalogero LauricellaErica BonazzinaGiulia SiravegnaMauro TruiniAlberto BardelliSalvatore Siena

Published in: ESMO open (2016)

Keyphrases

metastatic colorectal cancer
tyrosine kinase
epidermal growth factor receptor
small cell lung cancer
wild type